-
公开(公告)号:US20170304402A1
公开(公告)日:2017-10-26
申请号:US15588226
申请日:2017-05-05
申请人: INSERM (Institut National de la Santé et de la Recherche Médicale) , Assistance Publique - Hopitaux De Paris , Universite Pierre et Marie Curie (PARIS 6)
发明人: David Klatzmann , David Saadoun , Patrice Cacoub , Michèle Rosenzwajg , Eliane Piaggio , Gilbert Bensimon , Claude Bernard
IPC分类号: A61K38/20
CPC分类号: A61K38/2013
摘要: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
-
公开(公告)号:US10293028B2
公开(公告)日:2019-05-21
申请号:US15588226
申请日:2017-05-05
申请人: INSERM (Institut National de la Santé et de la Recherche Médicale) , Assistance Publique—Hopitaux De Paris , SORBONNE UNIVERSITE
发明人: David Klatzmann , David Saadoun , Patrice Cacoub , Michéle Rosenzwajg , Eliane Piaggio , Gilbert Bensimon , Claude Bernard
IPC分类号: A61K38/20
摘要: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
-
公开(公告)号:US10765723B2
公开(公告)日:2020-09-08
申请号:US16361902
申请日:2019-03-22
申请人: INSERM (Institut National de la Santé et de la Recherche Médicale) , Assistance Publique—Hopitaux De Paris , SORBONNE UNIVERSITE
发明人: David Klatzmann , David Saadoun , Patrice Cacoub , Michèle Rosenzwajg , Eliane Piaggio , Gilbert Bensimon , Claude Bernard
IPC分类号: A61K38/20
摘要: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
-
公开(公告)号:US20190351023A1
公开(公告)日:2019-11-21
申请号:US16361902
申请日:2019-03-22
申请人: INSERM (Institut National de la Sante et de la Recherche Medicale) , Assistance Publique - Hopitaux De Paris , SORBONNE UNIVERSITE
发明人: David Klatzmann , David Saadoun , Patrice Cacoub , Michèle Rosenzwajg , Eliane Piaggio , Gilbert Bensimon , Claude Bernard
IPC分类号: A61K38/20
摘要: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
-
公开(公告)号:US11559566B2
公开(公告)日:2023-01-24
申请号:US16925983
申请日:2020-07-10
申请人: INSERM (Institut National de la Sante et de la Recherche Medicale) , ASSISTANCE PUBLIQUE HOPITAUX DE PARIS , SORBONNE UNIVERSITE
发明人: David Klatzmann , David Saadoun , Patrice Cacoub , Michèle Rosenzwajg , Eliane Piaggio , Gilbert Bensimon , Claude Bernard
IPC分类号: A61K38/20
摘要: The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
-
-
-
-